303 related articles for article (PubMed ID: 23202466)
1. Junín virus pathogenesis and virus replication.
Grant A; Seregin A; Huang C; Kolokoltsova O; Brasier A; Peters C; Paessler S
Viruses; 2012 Oct; 4(10):2317-39. PubMed ID: 23202466
[TBL] [Abstract][Full Text] [Related]
2. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.
Emonet SF; Seregin AV; Yun NE; Poussard AL; Walker AG; de la Torre JC; Paessler S
J Virol; 2011 Feb; 85(4):1473-83. PubMed ID: 21123388
[TBL] [Abstract][Full Text] [Related]
3. IgG subclasses in human immune response to wild and attenuated (vaccine) Junin virus infection.
del Carmen Saavedra M; Sottosanti JM; Riera L; Ambrosio AM
J Med Virol; 2003 Mar; 69(3):447-50. PubMed ID: 12526057
[TBL] [Abstract][Full Text] [Related]
4. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain.
Albariño CG; Bird BH; Chakrabarti AK; Dodd KA; Flint M; Bergeron E; White DM; Nichol ST
J Virol; 2011 Oct; 85(19):10404-8. PubMed ID: 21795336
[TBL] [Abstract][Full Text] [Related]
5. The Ectodomain of Glycoprotein from the Candid#1 Vaccine Strain of Junin Virus Rendered Machupo Virus Partially Attenuated in Mice Lacking IFN-αβ/γ Receptor.
Koma T; Huang C; Aronson JF; Walker AG; Miller M; Smith JN; Patterson M; Paessler S
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004969. PubMed ID: 27580122
[TBL] [Abstract][Full Text] [Related]
6. Genomic features of attenuated Junín virus vaccine strain candidate.
Goñi SE; Iserte JA; Ambrosio AM; Romanowski V; Ghiringhelli PD; Lozano ME
Virus Genes; 2006 Feb; 32(1):37-41. PubMed ID: 16525733
[TBL] [Abstract][Full Text] [Related]
7. TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs.
Seregin AV; Yun NE; Poussard AL; Peng BH; Smith JK; Smith JN; Salazar M; Paessler S
Vaccine; 2010 Jul; 28(30):4713-8. PubMed ID: 20452431
[TBL] [Abstract][Full Text] [Related]
8. Epistastic Interactions within the Junín Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1 Vaccine.
York J; Nunberg JH
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070682
[TBL] [Abstract][Full Text] [Related]
9. The Glycoprotein of the Live-Attenuated Junin Virus Vaccine Strain Induces Endoplasmic Reticulum Stress and Forms Aggregates prior to Degradation in the Lysosome.
Manning JT; Yun NE; Seregin AV; Koma T; Sattler RA; Ezeomah C; Huang C; de la Torre JC; Paessler S
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996435
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2-mediated innate immune responses against Junín virus in mice lead to antiviral adaptive immune responses during systemic infection and do not affect viral replication in the brain.
Cuevas CD; Ross SR
J Virol; 2014 Jul; 88(14):7703-14. PubMed ID: 24760892
[TBL] [Abstract][Full Text] [Related]
11. Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
Ye C; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669332
[TBL] [Abstract][Full Text] [Related]
12. Junin virus vaccines.
Enria DA; Barrera Oro JG
Curr Top Microbiol Immunol; 2002; 263():239-61. PubMed ID: 11987817
[No Abstract] [Full Text] [Related]
13. Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.
Olschläger S; Flatz L
PLoS Pathog; 2013; 9(4):e1003212. PubMed ID: 23592977
[TBL] [Abstract][Full Text] [Related]
14. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
Hickerson BT; Westover JB; Wang Z; Lee YM; Gowen BB
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748396
[TBL] [Abstract][Full Text] [Related]
15. Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs.
Gowen BB; Hickerson BT; York J; Westover JB; Sefing EJ; Bailey KW; Wandersee L; Nunberg JH
J Virol; 2021 Jun; 95(14):e0039721. PubMed ID: 33952638
[TBL] [Abstract][Full Text] [Related]
16. The Virus-Host Interplay in Junín Mammarenavirus Infection.
Gallo GL; López N; Loureiro ME
Viruses; 2022 May; 14(6):. PubMed ID: 35746604
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the virulence attenuation process in Junín virus vaccine genealogy.
Goñi SE; Iserte JA; Stephan BI; Borio CS; Ghiringhelli PD; Lozano ME
Virus Genes; 2010 Jun; 40(3):320-8. PubMed ID: 20148301
[TBL] [Abstract][Full Text] [Related]
18. Junín virus. A XXI century update.
Gómez RM; Jaquenod de Giusti C; Sanchez Vallduvi MM; Frik J; Ferrer MF; Schattner M
Microbes Infect; 2011 Apr; 13(4):303-11. PubMed ID: 21238601
[TBL] [Abstract][Full Text] [Related]
19. [Phenotypic markers of attenuation in Junin virus strains recently isolated from individuals vaccinated with Junin Candid#1 strain].
Gamboa GS; Ambrosio AM; Maiza AS; Mariani M; Rodrigues Garcia Armôa G; Saavedra Mdel C
Medicina (B Aires); 2013; 73(4):303-9. PubMed ID: 23924527
[TBL] [Abstract][Full Text] [Related]
20. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever.
Seregin AV; Yun NE; Miller M; Aronson J; Smith JK; Walker AG; Smith JN; Huang C; Manning JT; de la Torre JC; Paessler S
J Virol; 2015 Jun; 89(11):5949-56. PubMed ID: 25810546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
